scholarly article | Q13442814 |
P50 | author | Carolyn Calfee | Q90427817 |
Michael Matthay | Q93363551 | ||
P2093 | author name string | Benjamin A Goldstein | |
Joseph E Levitt | |||
Rosemary Vojnik | |||
P2860 | cites work | Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 |
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
APACHE II: a severity of disease classification system | Q29547729 | ||
Acute respiratory distress syndrome: the Berlin Definition | Q29615138 | ||
Incidence and outcomes of acute lung injury | Q29615139 | ||
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 | ||
Randomized, Placebo-controlled Clinical Trial of an Aerosolized β2-Agonist for Treatment of Acute Lung Injury | Q30425088 | ||
Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting | Q33814687 | ||
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction | Q33917874 | ||
Comparison of two fluid-management strategies in acute lung injury | Q34528886 | ||
Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. | Q34528894 | ||
Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study | Q34545611 | ||
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study | Q34665113 | ||
Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome | Q35007498 | ||
Active and Passive Cigarette Smoking and Acute Lung Injury after Severe Blunt Trauma | Q35107236 | ||
Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial | Q35697000 | ||
Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation | Q35877104 | ||
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. | Q36102830 | ||
Toward early identification of acute lung injury in the emergency department | Q36407502 | ||
Treatment of acute lung injury: historical perspective and potential future therapies | Q36565930 | ||
Nonventilatory treatments for acute lung injury and ARDS. | Q36758874 | ||
Randomized clinical trial of activated protein C for the treatment of acute lung injury | Q36889970 | ||
Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study | Q36916259 | ||
Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study | Q37147095 | ||
Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure | Q37378563 | ||
Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee | Q40760476 | ||
Acute lung injury outside of the ICU: incidence in respiratory isolation on a general ward | Q44364967 | ||
Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion | Q47784098 | ||
Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome | Q47952677 | ||
Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. | Q51912384 | ||
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 | ||
The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults | Q70810774 | ||
Clinical risks for development of the acute respiratory distress syndrome | Q72501931 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | acute lung injury | Q4677935 |
P304 | page(s) | 1929-1937 | |
P577 | publication date | 2013-08-01 | |
P1433 | published in | Critical Care Medicine | Q5186605 |
P1476 | title | Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*. | |
P478 | volume | 41 |
Q42331973 | A mortality score for acute respiratory distress syndrome: predicting the future without a crystal ball |
Q93104168 | A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome |
Q64111457 | ARDS in Obese Patients: Specificities and Management |
Q94029681 | Acute respiratory distress syndrome |
Q38204194 | Applying metabolomics to uncover novel biology in ARDS. |
Q34625416 | Approach to the patient with the acute respiratory distress syndrome |
Q46554070 | Challenges in predicting which patients will develop ARDS. |
Q38664603 | Clinical trials in acute respiratory distress syndrome: challenges and opportunities. |
Q97566015 | Comprehensive mapping of immune perturbations associated with severe COVID-19 |
Q93020359 | Diagnostic and prognostic values of serum activin-a levels in patients with acute respiratory distress syndrome |
Q38775825 | Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease? |
Q64111565 | Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway |
Q35672031 | Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. |
Q42172531 | Lung Injury Prediction Score Is Useful in Predicting Acute Respiratory Distress Syndrome and Mortality in Surgical Critical Care Patients |
Q64108714 | Machine learning for patient risk stratification for acute respiratory distress syndrome |
Q39691608 | Magnetic resonance imaging provides sensitive in vivo assessment of experimental ventilator-induced lung injury |
Q38381656 | Personalized medicine for ARDS: the 2035 research agenda |
Q34299807 | Preventing ARDS: progress, promise, and pitfalls |
Q27009192 | Prevention of acute respiratory distress syndrome |
Q92545193 | RNAi therapeutic strategies for acute respiratory distress syndrome |
Q64119548 | Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients |
Q54407314 | SpO2/FiO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk |
Q42849281 | Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice |
Q33414615 | Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study |
Q36641496 | Timing of Intubation and Clinical Outcomes in Adults With Acute Respiratory Distress Syndrome |
Q92064060 | Towards Reliable ARDS Clinical Decision Support: ARDS Patient Analytics with Free-text and Structured EMR Data |
Q47995348 | Valproic acid mitigates the inflammatory response and prevents acute respiratory distress syndrome in a murine model of Escherichia coli pneumonia at the expense of bacterial clearance |
Q51420387 | Ventilator-induced Lung Injury |
Q51542927 | What's new in ARDS: can we prevent it? |
Search more.